|
XB--1005168
Papers associated with slc1a2 (and Disease Ontology)
???pagination.result.count???
???pagination.result.page??? 1
| Sort Newest To Oldest | Sort Oldest To Newest |
Advancements in the use of xenopus oocytes for modelling neurological disease for novel drug discovery., O'Connor EC, Kambara K, Bertrand D., Expert Opin Drug Discov. February 1, 2024; 19 (2): 173-187.  |
|
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease., Iovino L, Giusti V, Pischedda F, Giusto E, Plotegher N, Marte A, Battisti I, Di Iacovo A, Marku A, Piccoli G, Bandopadhyay R, Perego C, Bonifacino T, Bonanno G, Roseti C, Bossi E, Arrigoni G, Bubacco L, Greggio E, Hilfiker S, Civiero L., Acta Neuropathol. July 1, 2022; 144 (1): 81-106.  |
|
Transport rate of EAAT2 is regulated by amino acid located at the interface between the scaffolding and substrate transport domains., Duffield M, Patel A, Mortensen OV, Schnur D, Gonzalez-Suarez AD, Torres-Salazar D, Fontana ACK., Neurochem Int. October 1, 2020; 139 104792. |
|
Interaction of Excitatory Amino Acid Transporters 1 - 3 (EAAT1, EAAT2, EAAT3) with N-Carbamoylglutamate and N-Acetylglutamate., Burckhardt BC, Burckhardt G., Cell Physiol Biochem. January 1, 2017; 43 (5): 1907-1916. |
???pagination.result.page??? 1